Matthew Ronsheim Innoviva, Inc. (INVA) insider trading activity

Matthew Ronsheim is of Innoviva, Inc.. Currently has a direct ownership of 40,510 shares of INVA, which is worth approximately $751,460. The most recent transaction as insider was on May 20, 2024, when has been sold 268 shares (Common Stock) at a price of $16.13 per share, resulting in proceeds of $4,322. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.5K

0.66% 3M change

n/a 12M change

Total Value Held $751,460

Matthew Ronsheim Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2024	SELL Payment of exercise price or tax liability	$4,322 $16.13 p/Share	268 Reduced 0.66%	40,510 Common Stock
Mar 05 2024	BUY Grant, award, or other acquisition	$189,987 $14.88 p/Share	12,768 Added 23.84%	40,778 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$12,750 $15.8 p/Share	807 Reduced 2.8%	28,010 Common Stock
Jan 18 2024	SELL Payment of exercise price or tax liability	$25,680 $16.05 p/Share	1,600 Reduced 5.26%	28,817 Common Stock

Also insider at

ETTX

Entasis Therapeutics Holdings Inc. Healthcare

Chief of Pharma Sciences & MFG